Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamide

Yaoxue Xuebao

Volumn 45, Issue 1, 2010, Pages 66-71

  Yang, Da Cheng ^a   Yan, Ju Fang ^b   Xu, Jin ^a   Ye, Fei ^b   Zhou, Zu Wen ^a   Zhang, Wei Yu ^b   Fan, Li ^a   Chen, Xin ^b  

^a SOUTHWEST UNIVERSITY   (China)

^b Chengdu Diao Pharmaceutical Group Co Ltd   (China)

Author keywords

glucosidase; amino ketone; Diabetes mellitus; Mannich reaction; PPAR; Sulfanilamide

Indexed keywords

2 BUTANONE; 4 (1 ARYL 3 OXO 5 PHENYLPENTYLAMINO)BENZENESULFONAMIDE DERIVATIVE; ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BENZENESULFONAMIDE DERIVATIVE; MANNICH BASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; SULFANILAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DIABETES CONTROL; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME INHIBITION; INFRARED SPECTROSCOPY; ONE POT SYNTHESIS; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ALPHA-GLUCOSIDASES; DRUG DESIGN; HYPOGLYCEMIC AGENTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFANILAMIDES; SULFONAMIDES;

EID: 77950620068     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rosenstock J, Samole E, Muchmore D, et al. Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients [J]. Diabetes Care, 1996, 19: 1194-1199.
2. Scheen AJ. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials [J]. Diabetes Metab, 1998, 21: 311-320.
3. Blickle JF, Andres E, Brogard JM. Current status of the treatment of type 2 diabetes mellitus alpha-glucosidase inhibitors [J]. Rev Med Interne, 1999, 20: 375-383.
4. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [J]. N Engl J Med, 2007, 356: 2457-2471. (Pubitemid 46919772)
5. Chen HT, Jing YK, Ji ZZ. Synthesis and anti-inflammatory and anticancer activities of 2-(E)-(un)substituted benzylidene cyclopentanones and their Mannich base hydrochlorides [J]. Acta Pharm Sin, 1991, 26: 183-192.
6. Yang DC, Fan L, Liu HP, et al. A kind of new Mannich base compounds, and their uses for the treatment and /or precaution against leukaemia: CN, 200710092667 [P]. 2007-10-109
7. Karthikeyan MS, Prasad DJ, Poojary B, et al. Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety [J]. Bioorg Med Chem, 2006, 14: 7482-7489. (Pubitemid 44486797)
8. Joshi S, Khosla N, Khare D, et al. Synthesis and in vitro study of novel Mannich bases as antibacterial agents [J]. Bioorg Med Chem Lett, 2005, 15: 221-226. (Pubitemid 39575814)
9. Karczmarzyk Z, Malinka W. Structural characterization of analgesic isothiazolopyridines of Mannich base type; X-ray analysis of 2-[(4-phenylpiperazin-l-yl)ethyl]-and 2-[(4-methylpiperazin-1-yl) methyl]-4,6-dimethylisothiazolo-[5,4-b] pyridin-3 (2H)-ones [J]. J Mol Struct, 2008, 888: 160-167.
10. Joshi S, Khosla N, Tiwari P. In vitro study of some medicinally important Mannich bases derived from antitubercular agent [J]. Bioorg Med Chem, 2004, 12: 571-576.
11. Xu J, Yan JF, Fan L, et al. Synthesis and α-glucosidase inhibitory activity of N-(1, 5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid [J]. Acta Pharm Sin, 2009, 44: 48-55.
12. Li QL, Yang DC, Yan JF, et al. A kind of new β-amino ketone/alcohol derivatives and its use: CN, 200810148122.X. [P]. 2008-10-14.
13. Hao GF, Yang GF. Progress in the new generation nonpeptide sulfonamide anti-HIV protease inhibitor darunavir [J]. Chin J Org Chem, 2008, 28: 1545-1552.
14. Feng J, Guo YS, Lu Y, et al. Design, virtual screening and synthesis of PPAR agonists [J]. Acta Chim Sin, 2004, 62: 1544-1550.
15. Li BN, Cai SZ, Du DM, et al. Synthesis of phosphinopeptides via the Mannich ligation [J]. Org Lett, 2007, 9: 2257-2260.
16. Kidwai M, Mishra NK, Bansal V, et al. Novel one-pot Cu-nanoparticles- catalyzed Mannich reaction [J]. Tetrahedron Lett, 2009, 50: 1355-1358.
17. Yang DC, Zhang GL, Yang Y, et al. The Mannich reaction of 4-methylacetophenone with aromatic aldehydes and aromatic amines [J]. Chem J Chin Univ, 2000, 21: 1694-1696.
18. Fan L, Yang DC. The Mannich reaction of ethyl 4-aminobenzoate with 4-phenyl-2-butanone and aromatic aldehydes [J]. J Southwest Chin Norm Univ (Nat Sci), 1998, 23: 726-729.
19. Yang DC. The Mannich reaction of 4-phenyl-2-butanone with aromatic aldehydes and aromatic amines [J]. J Southwest Chin Norm Univ (Nat Sci), 1996, 21: 354-359.
20. 2 catalyst [J]. Chin Chem Lett, 2009, 20: 407-410.
21. Sahoo S, Joseph T, Halligudi SB. Mannich reaction in Bronsted acidic ionic liquid: a facile synthesis of β-amino carbonyl compounds [J]. J Mol Catal A: Chem, 2006, 244: 179-182. (Pubitemid 43121413)
22. Takahashi E, Fujisawa H, Mukaiyama T. Lithium acetate-catalyzed Mannich-type reaction between trimethylsilyl enolates and aldimines in a water-containing DMF [J]. Chem Lett, 2004, 33: 936-937. (Pubitemid 39295806)
23. Kidwai M, Bhatnagar D, Mishra NK, et al. CAN catalyzed synthesis of β-amino carbonyl compounds via Mannich reaction in PEG [J]. Catal Commun, 2008, 9: 2547-2549.
24. Ishitani H, Ueno M, Kobayashi S. Catalytic enantioselective Mannich-type reactions using a novel chiral zirconium catalyst [J]. J Am Chem Soc, 1997, 119: 7153-7154. (Pubitemid 27357307)
25. Liu BY, Zhao DS, Xu DQ, et al. Amide ionic liquids (AILs) / L-proline synergistic catalyzed asymmetric Mannich reactions [J]. Chem Res Chin Univ, 2007, 23: 163-168.
26. Guo ZR. Strategy of molecular drug design: dual-target drug design [J]. Acta Pharm Sin, 2009, 44: 209-218.